Dosage & Reconstitution Guide

BPC-157 + TB-500 Dosage & Reconstitution Guide

A clear educational guide covering BPC-157 + TB-500 blend reconstitution, unit conversions, phased protocol examples, supplies, storage, injection technique, tissue repair research notes and safety considerations.

Important: This content is for educational and research reference only. It is not medical advice, dosing advice or a treatment recommendation. Peptide Hub Australia does not sell peptides and does not recommend human use.

Quickstart Highlights

Blend: BPC-157 + TB-500
Common vial size: 10mg total blend
Blend ratio: 5mg BPC-157 + 5mg TB-500
Example reconstitution: 3.0mL bacteriostatic water
Total concentration: approximately 3.33mg/mL
Each peptide concentration: approximately 1.67mg/mL
U-100 syringe maths: 1 unit = 0.01mL = approximately 33.3mcg total blend
Common research range discussed: 600-1,000mcg total blend daily
Storage after mixing: refrigerate at 2-8°C and avoid freeze-thaw cycles

What is BPC-157 + TB-500?

BPC-157 + TB-500 is a blended research peptide product that usually contains equal amounts of BPC-157 and TB-500. A 10mg blend commonly contains 5mg of BPC-157 and 5mg of TB-500.

In research discussions, BPC-157 is commonly associated with cytoprotective, gastrointestinal, musculoskeletal and wound-healing pathways. TB-500 is commonly associated with tissue repair, cell migration, angiogenesis and wound-healing research.

BPC-157 + TB-500 Reconstitution Example

The example below is based on a 10mg total blend vial mixed with 3.0mL bacteriostatic water.

Reconstitution Maths

10mg total blend ÷ 3.0mL = 3.33mg/mL total blend
3.33mg/mL = 3,333mcg/mL total blend
Each peptide = approximately 1.67mg/mL
1 unit on a U-100 syringe = 0.01mL
3,333mcg/mL × 0.01mL = approximately 33.3mcg total blend per unit

BPC-157 + TB-500 Unit Conversion Table

Total Blend Amount	Amount of Each Peptide	U-100 Units	mL
600mcg	300mcg BPC + 300mcg TB-500	18 units	0.18mL
800mcg	400mcg BPC + 400mcg TB-500	24 units	0.24mL
1,000mcg / 1mg	500mcg BPC + 500mcg TB-500	30 units	0.30mL

Standard Gradual Research Example

Phase	Total Daily Amount	Each Peptide	U-100 Units	mL
Weeks 1-2	600mcg	300mcg + 300mcg	18 units	0.18mL
Weeks 3-4	800mcg	400mcg + 400mcg	24 units	0.24mL
Weeks 5-8	600mcg	300mcg + 300mcg	18 units	0.18mL

Advanced Research Example

Phase	Total Daily Amount	Each Peptide	U-100 Units	mL
Weeks 1-2	1,000mcg	500mcg + 500mcg	30 units	0.30mL
Weeks 3-4	800mcg	400mcg + 400mcg	24 units	0.24mL
Weeks 5-8	600mcg	300mcg + 300mcg	18 units	0.18mL

Research note: This is a research-style measurement example only. Human dose-finding data for this blend is limited, so this page should not be treated as personal dosing advice.

Reconstitution Steps

Confirm the total blend size and ratio before calculating concentration.
Draw 3.0mL bacteriostatic water using sterile technique.
Inject the bacteriostatic water slowly down the inside wall of the vial.
Avoid blasting the powder directly and avoid creating foam.
Gently swirl or roll the vial until dissolved.
Do not shake.
Label the vial with the reconstitution date and concentration.
Store refrigerated at 2-8°C, protected from light.

Supplies Needed

BPC-157 + TB-500 Vials

8-week example: approximately 4 × 10mg blend vials.
12-week example: approximately 6 × 10mg blend vials.
16-week example: approximately 8 × 10mg blend vials.

Insulin Syringes

Daily example: 7 syringes per week.
8 weeks: approximately 56 syringes.
12 weeks: approximately 84 syringes.
16 weeks: approximately 112 syringes.

Bacteriostatic Water

Per 10mg blend vial: 3.0mL bacteriostatic water.
8-week example: 4 vials × 3.0mL = 12mL total, so 2 × 10mL bottles may be needed.
12-week example: 6 vials × 3.0mL = 18mL total, so 2 × 10mL bottles may be needed.
16-week example: 8 vials × 3.0mL = 24mL total, so 3 × 10mL bottles may be needed.

Alcohol Swabs

Per administration: one swab for the vial stopper and one for the injection site.
Per week: approximately 14 swabs based on daily administration.
8 weeks: around 112 swabs, so 2 × 100-count boxes may be needed.
12 weeks: around 168 swabs, so 2 × 100-count boxes may be needed.
16 weeks: around 224 swabs, so 3 × 100-count boxes may be needed.

Protocol Overview

Goal discussed in research: tissue repair, wound healing and musculoskeletal recovery pathways.
Schedule example: once-daily subcutaneous administration.
Common amount discussed: 600-1,000mcg total blend daily.
Each peptide amount: 300-500mcg of BPC-157 and 300-500mcg of TB-500 daily.
Example reconstitution: 3.0mL bacteriostatic water per 10mg blend vial.
Concentration: approximately 3.33mg/mL total blend.
Cycle length: 8-12 weeks is commonly discussed, with optional extension to 16 weeks.
Storage: lyophilised frozen, reconstituted refrigerated and not frozen after mixing.

How BPC-157 + TB-500 Works

BPC-157 is discussed in preclinical research for angiogenesis, nitric oxide pathway modulation, cytoprotective effects and gastrointestinal, musculoskeletal and neurological tissue research.

TB-500 is a thymosin beta-4 fragment discussed for actin-related cell migration, wound healing, angiogenesis and anti-inflammatory pathway research.

The blend is commonly discussed because the two peptides may have complementary tissue repair mechanisms, with BPC-157 often linked to trophic and anti-inflammatory effects and TB-500 linked to cell migration and angiogenesis.

Potential Benefits Discussed in Research

Tissue repair research
Wound healing pathway discussions
Tendon, ligament, muscle and soft tissue research
Angiogenesis research
Cell migration research
Inflammation pathway discussions
Gastroprotective and cytoprotective BPC-157 research
Recovery-related musculoskeletal research

Reported Side Effects and Limitations

Mild injection-site redness
Itching or local irritation
Tenderness or bruising at the injection site
Human data is limited
Not approved for routine human use
Often sold for research purposes only
May be prohibited in competitive sports contexts
Not a guaranteed treatment for injury, pain, inflammation or tissue repair

Important safety note: BPC-157 + TB-500 should not be presented as a proven injury-repair, tendon-healing, ligament-healing or performance compound. Evidence is still limited, especially for human use.

Storage Instructions

Lyophilised powder: store frozen at around -20°C in dry, dark conditions.
After reconstitution: refrigerate at 2-8°C.
Use window: commonly discussed as within 4-6 weeks after reconstitution.
Do not freeze after mixing: avoid freezing reconstituted solution.
Protect from light: keep the vial away from unnecessary light exposure.
Avoid: heat, sunlight, moisture, contamination and repeated freeze-thaw cycles.
Practical note: allow vials to reach room temperature before opening to reduce condensation uptake.

Injection Technique Notes

This section is general educational information only. It is not personal injection instruction.

Use a new sterile insulin syringe for each administration.
Clean the vial stopper and injection site with alcohol and allow both to dry completely.
Common subcutaneous sites discussed include abdomen, thighs, upper arms and flank.
For abdomen use, avoid injecting too close to the navel.
Rotate injection sites systematically to reduce local irritation and lipohypertrophy risk.
Pinch a skinfold and insert into subcutaneous tissue at an appropriate angle.
Do not aspirate for subcutaneous injections.
Inject slowly and steadily.
Wait a few seconds before withdrawing the needle to help reduce leakage.
Apply gentle pressure if needed and do not rub the site vigorously.
Dispose of used sharps safely in a sharps container.

Lifestyle Factors That May Matter

Protein intake: adequate protein may support normal tissue repair and recovery processes.
Rehabilitation: appropriate rehab protocols matter more than relying on any single compound.
Training load: avoid overloading the injured area too quickly.
Sleep: 7-9 hours of quality sleep supports recovery and tissue regeneration.
Inflammation management: balanced nutrition, stress reduction and recovery habits may support overall outcomes.
Tracking: documenting amount, date, site and observations can make tolerance patterns easier to review.

Use the Peptide Calculator

If your vial size, water volume or target amount is different, use the Peptide Hub Australia calculator to work out concentration, mL and syringe units.

Calculate BPC-157 + TB-500 Units

Enter your vial size, BAC water amount and target amount to calculate concentration and syringe units.

Open Peptide Calculator

Where to Compare BPC-157 + TB-500 Suppliers

Peptide Hub Australia does not sell BPC-157, TB-500 or any other peptides. We compare Australian peptide vendors, package audits, pricing and supplier information to help users review the market more clearly.

Compare Vendors Compare Prices View Package Audits

Frequently Asked Questions

How much BAC water do you add to a 10mg BPC-157 + TB-500 blend?

A common educational example is 3.0mL bacteriostatic water added to a 10mg blend vial, creating a total concentration of approximately 3.33mg/mL.

How many units is 600mcg of BPC-157 + TB-500?

If a 10mg blend vial is mixed with 3.0mL, 600mcg total blend is approximately 18 units on a U-100 insulin syringe, equal to around 0.18mL.

How many units is 800mcg of BPC-157 + TB-500?

If a 10mg blend vial is mixed with 3.0mL, 800mcg total blend is approximately 24 units on a U-100 insulin syringe, equal to around 0.24mL.

How many units is 1mg of BPC-157 + TB-500?

If a 10mg blend vial is mixed with 3.0mL, 1mg total blend is approximately 30 units on a U-100 insulin syringe, equal to around 0.30mL.

How much of each peptide is in a 600mcg blend amount?

In a 1:1 blend, 600mcg total blend provides approximately 300mcg BPC-157 and 300mcg TB-500.

How long does one 10mg blend vial last?

At 600mcg total blend daily, one 10mg vial lasts around 16 days. At 800mcg daily, it lasts around 12 days. At 1,000mcg daily, it lasts around 10 days.

Is this a personal dosing recommendation?

No. This page is an educational reconstitution and measurement guide only. It is not medical advice or a personal protocol.